Cart
sales@molnova.com
Acetyl-(Tyr1,D-Arg2)-GRF (1-29) amide (human)
CAS No. 93942-91-7
Acetyl-(Tyr1,D-Arg2)-GRF (1-29) amide (human)( ——— )
Catalog No. M39934 CAS No. 93942-91-7
Acetyl-(D-Arg2)-GRF (1-29) amide (human) is an antagonist of growth hormone releasing factor (GRF). Acetyl-(D-Arg2)-GRF (1-29) amide (human) inhibits the release of growth hormone (GH) and can be used for endocrine research.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
Biological Information
-
Product NameAcetyl-(Tyr1,D-Arg2)-GRF (1-29) amide (human)
-
NoteResearch use only, not for human use.
-
Brief DescriptionAcetyl-(D-Arg2)-GRF (1-29) amide (human) is an antagonist of growth hormone releasing factor (GRF). Acetyl-(D-Arg2)-GRF (1-29) amide (human) inhibits the release of growth hormone (GH) and can be used for endocrine research.
-
DescriptionAcetyl-(D-Arg2)-GRF (1-29) amide (human) is an antagonist of growth hormone releasing factor (GRF). Acetyl-(D-Arg2)-GRF (1-29) amide (human) inhibits the release of growth hormone (GH) and can be used for endocrine research.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
RecptorGrowth hormone releasing factor, GRF; Growth hormone, GH
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number93942-91-7
-
Formula Weight3485.1
-
Molecular FormulaC154H255N47O43S
-
Purity>98% (HPLC)
-
SolubilityH2O : 50 mg/mL (14.35 mM; ultraphonic)
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Lumpkin MD, et al. Blockade of growth hormone-releasing factor (GRF) activity in the pituitary and hypothalamus of the conscious rat with a peptidic GRF antagonist. Endocrinology. 1989 Mar;124(3):1522-31. ?
molnova catalog
related products
-
Coluracetam
A nootropic agent that enhances high-affinity choline uptake.
-
GRPP (human)
GRPP (human) is a 30 amino acid Gcg-derived peptide. GRPP (human) causes slight increases in plasma insulin and decreases in plasma glucagon. GRPP (human) does not affect insulin secretion in rat islets.
-
TAK-448
TAK-448 (MVT-602) is a potent and full KISS1R agonist with an IC50 of 460 pM and an EC50 of 632 pM.TAK-448 has been used in trials studying the treatment of Prostate Cancer, Low Testosterone, Prostatic Neoplasms, and Hypogonadotropic Hypogonadism.
